Concord Biotech Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2025, recommended Final Dividend of 10.70 per equity share.
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Concord Biotech Limited, at its meeting held on May 29, 2025, has recommended a Final Dividend of Rs. 10.70 per equity share for its shareholders. This dividend is subject to approval by the shareholders at the upcoming Annual General Meeting (AGM). The record date and payment date will be communicated separately by the company. Once approved, this would result in a cash outflow from the company to its eligible shareholders.
This is a positive signal for shareholders as it reflects the company's ability to return profits. The dividend yield relative to the stock price will determine its attractiveness; shareholders should check the ex-dividend date to be eligible for the payout.